Results 201 to 210 of about 379,792 (264)
This study introduces β‐glucan‐shielded apremilast laden nanomicelles that withstand gastrointestinal degradation, selectively accumulate in inflamed colon tissue, and modulate the microbiota–gut–brain axis. The formulation restores barrier integrity, reduces systemic and neuroinflammation, and improves anxiety‐ and depression‐like behaviors in colitis
Chandrashekhar Jori +10 more
wiley +1 more source
The membrane‐active peptide Pep19‐2.5 reduces harmful inflammation by blocking activation of the NLRP3 inflammasome at trans‐Golgi network membranes. By targeting key membrane interactions, Pep19‐2.5 suppresses inflammatory IL‐1β production and alleviates allergic airway inflammation in mice, leading to reduced immune cell infiltration and improved ...
Jonas Engelhardt +16 more
wiley +1 more source
An integrated Human Airway Microbiome Gene Catalog (iHAMGC) is constructed from 12,273 metagenomic airway samples, providing a high‐resolution reference of respiratory microbial genes. The catalog enables systematic exploration of taxonomic and functional variation across airway niches and geographic regions, revealing site‐specific and region ...
Qing Zhang +15 more
wiley +1 more source
A previously unrecognized microprotein, MP104, encoded by ZEB1‐AS1, emerges as a critical driver of colorectal cancer progression. MP104 links ubiquitin‐mediated protein degradation with translational reprogramming via the UBE2O–AMPKα2–mTOR–EIF4B axis, revealing an unrecognized layer of oncogenic regulation.
Fang Chen +14 more
wiley +1 more source
This study unveiled that METTL14 mediates m6A modification of WDR72 mRNA to stabilize and enhance WDR72 expression, which disrupts TRIM31‐mediated ubiquitination of CBX8 protein and retards its degradation, finally the elevated CBX8 contributes to tumor stemness.
Huijuan Zeng +13 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Neurology, 2004
The effects of a low-carbohydrate, ketogenic diet (LCKD) on sleepiness and other narcolepsy symptoms were studied. Nine patients with narcolepsy were asked to adhere to the Atkins' diet plan, and their symptoms were assessed using the Narcolepsy Symptom Status Questionnaire (NSSQ).
A M, Husain +4 more
openaire +2 more sources
The effects of a low-carbohydrate, ketogenic diet (LCKD) on sleepiness and other narcolepsy symptoms were studied. Nine patients with narcolepsy were asked to adhere to the Atkins' diet plan, and their symptoms were assessed using the Narcolepsy Symptom Status Questionnaire (NSSQ).
A M, Husain +4 more
openaire +2 more sources
Nihon rinsho. Japanese journal of clinical medicine, 1997
The effect of diet therapy on borderline type was discussed here. First the effect of calorie restriction on preventing the development of diabetes, using OLETF rat model was shown. Second, the influence of sucrose and ethanol on insulin secretion and insulin sensitivity was studied.
M, Narimiya, Y, Mori, Y, Ikeda
openaire +3 more sources
The effect of diet therapy on borderline type was discussed here. First the effect of calorie restriction on preventing the development of diabetes, using OLETF rat model was shown. Second, the influence of sucrose and ethanol on insulin secretion and insulin sensitivity was studied.
M, Narimiya, Y, Mori, Y, Ikeda
openaire +3 more sources
Diet as risk and therapy for cancer
Medical Clinics of North America, 1993This article provides a brief overview of the scientific rationale for dietary guidelines that may reduce the risk of some types of cancers--breast, colon, and prostate in particular. Dietary modification clinical trials currently sponsored by the National Cancer Institute are described.
C, Clifford, B, Kramer
openaire +2 more sources

